Bristol Myers Squibb ices licensing pact with ArsenalBio to draft its designer T cells into the solid tumor fight

Back in late 2019, South San Francisco’s ArsenalBio uncorked an $85 million round to kickstart its designer T cell project with some splashy backers on board. Since then, Arsenal went to work: tripling its team, workshopping its product strategy and — in its biggest move yet — bringing on a…

Click to view original post